World

Serum Institute begins the last phase of the clinical trial

Phase III or last stage of the clinical trial of the Covid-19 ‘Covishield’ vaccine, which is being developed by the University of Oxford and manufactured by the Serum Institute of India (SII), began today at the Sassoon General Hospital, administered for the state, in Pune, Maharashtra on Monday, a senior …

Read More »